Rapid increase in the prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1989-1991

J Antimicrob Chemother. 1992 Sep;30(3):289-93. doi: 10.1093/jac/30.3.289.

Abstract

At St Elizabeth Hospital Medical Center in Youngstown, Ohio, USA, the first blood culture isolate of Enterococcus faecalis with high-level gentamicin resistance (MIC > 2000 mg/L) was seen in 1985, and the prevalence of high-level gentamicin resistance among enterococci isolated from blood cultures during 1985-8 was 9%. During the period 1989-91, the prevalence of high-level gentamicin resistance among enterococci isolated from blood cultures increased to 35% (44 of 126 strains). Increases in the prevalence of high-level resistance to amikacin, tobramycin, netilmicin, kanamycin and streptomycin were also demonstrated. Ten of 44 strains (23%) with high-level gentamicin resistance did not exhibit high-level resistance to streptomycin. Of the 126 strains of enterococci, 52% had high-level resistance to at least one aminoglycoside.

Publication types

  • Comparative Study

MeSH terms

  • Aminoglycosides
  • Anti-Bacterial Agents / pharmacology*
  • Bacteremia / microbiology*
  • Bacteriological Techniques
  • Drug Resistance, Microbial
  • Enterococcus / drug effects*
  • Enterococcus / isolation & purification
  • Enterococcus faecalis / drug effects
  • Enterococcus faecalis / isolation & purification
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / isolation & purification
  • Humans
  • Species Specificity
  • Time Factors

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents